Clinical trial
Clinical Efficacy and Safety of Sericin Hydrogel Sheet Impregnated With Bird's Nest Extract in Prevention of Hypertrophic Scar Development at Split-thickness Skin Graft Donor Site
NCT04997863 is registered in ClinicalTrials.gov with Chulalongkorn University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Efficacy and Safety of Sericin Hydrogel Sheet Impregnated With Bird's Nest Extract in Prevention of Hypertrophic Scar Development at Split-thickness Skin Graft Donor Site
- Lead sponsor
- Chulalongkorn University
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- November 1, 2021
- Completion date
- October 31, 2022
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
donor site complication, scar conditions and fibrosis of skin, skin graft scar, wound